产品中心Cell Resources
联系我们CONTACT US
- 400-999-210024小时服务热线
产品概述
产品简介
产品说明
产品形态 | 液体 |
产品浓度 | 1× |
产品规格 | 100mL/125mL×4 |
细菌检测 | 阴性 |
真菌检测 | 阴性 |
支原体检测 | 阴性 |
细胞生长实验 | 细胞生长良好,形态正常 |
内毒素含量(EU/mL) | ≤3 |
储存条件 | 2~8℃,避光储存 |
运输条件 | 冰袋冷藏运输 |
有效期 | 3个月 |
注意事项
参考文献
-
A pan-cancer analysis of DDR1 in prognostic signature and tumor immunity, drug resistance (2023-04-08)
作者:Longfei Yang:1.Medical School of Nantong University, 19 Qixiu Road, Nantong, 226001, Jiangsu, China. ; 2.Department of Urology, Affiliated Wuxi No. 2 Hospital of Nanjing Medical University, 68 Zhongshan Road, Wuxi, 214002, Jiangsu, China. ; Yuwei Zhang:1.Medical School of Nantong University, 19 Qixiu Road, Nantong, 226001, Jiangsu, China. ; 2.Department of Urology, Affiliated Wuxi No. 2 Hospital of Nanjing Medical University, 68 Zhongshan Road, Wuxi, 214002, Jiangsu, China. ; Yifan Tang:1.Department of Urology, Affiliated Wuxi No. 2 Hospital of Nanjing Medical University, 68 Zhongshan Road, Wuxi, 214002, Jiangsu, China. ; Yang Wang:1.Department of Urology, Affiliated Wuxi No. 2 Hospital of Nanjing Medical University, 68 Zhongshan Road, Wuxi, 214002, Jiangsu, China. ; Peng Jiang:1.Department of Urology, Affiliated Wuxi No. 2 Hospital of Nanjing Medical University, 68 Zhongshan Road, Wuxi, 214002, Jiangsu, China. ; Fengping Liu:1.Wuxi School of Medicine, Jiangnan University, 1800 Li
期刊:A pan-cancer analysis of DDR1 in prognostic signature and tumor immunity, drug resistance
DOI:10.1038/s41598-023-27975-9
影响因子 :4.6
引用产品: HK-2 细胞 , 786-O [786-0] 细胞 , Caki-1 细胞 , SV-HUC-1 细胞 , T24 [T-24] 细胞 , 5637 细胞 , RWPE-1 细胞 , PC-3 细胞 , DU 145 细胞 , DMEM高糖 培养基 , RPMI-1640 培养基 , Ham's F-12K 培养基 , 人前列腺上皮细胞完全培养基
-
Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis. (2022-09-21)
作者:Longfei Yang:1.Medical School of Nantong University, Nantong, China. ; 2.Department of Urology, Affiliated Wuxi No. 2 Hospital of Nanjing Medical University, Wuxi, China. ; Yuwei Zhang:1.Medical School of Nantong University, Nantong, China. ; 2.Department of Urology, Affiliated Wuxi No. 2 Hospital of Nanjing Medical University, Wuxi, China. ; Yang Wang:1.Department of Urology, Affiliated Wuxi No. 2 Hospital of Nanjing Medical University, Wuxi, China. ; Peng Jiang:1.Department of Urology, Affiliated Wuxi No. 2 Hospital of Nanjing Medical University, Wuxi, China. ; Fengping Liu:1.Wuxi School of Medicine, Jiangnan University, Wuxi, China. ; Ninghan Feng:1.Medical School of Nantong University, Nantong, China. ; 2.Department of Urology, Affiliated Wuxi No. 2 Hospital of Nanjing Medical University, Wuxi, China. ;
期刊:Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis.
影响因子 :6.0
引用产品: SV-HUC-1 细胞 , T24 [T-24] 细胞 , 5637 细胞 , HK-2 细胞 , 786-O [786-0] 细胞 , Caki-1 细胞 , RWPE-1 细胞 , PC-3 细胞 , DU 145 细胞 , Ham's F-12K 培养基 , DMEM高糖 培养基 , 人前列腺上皮细胞完全培养基 , RPMI-1640 培养基
-
Long non-coding DANCR targets miR-185-5p to upregulate LIM and SH3 protein 1 promoting prostate cancer via the FAK/PI3K/AKT/GSK3β/snail pathway (2005-01-20)
作者:Wendong Sun:1.Department of Urology, The Second Hospital of Shandong University, Jinan City, Shandong, China. ; Shulu Zu:1.Department of Urology, The Second Hospital of Shandong University, Jinan City, Shandong, China. ; Guangfeng Shao:1.Department of Urology, The Second Hospital of Shandong University, Jinan City, Shandong, China. ; Wenzhen Wang:1.Department of Urology, The Second Hospital of Shandong University, Jinan City, Shandong, China. ; Fangxin Gong:1.Department of Urology, The Second Hospital of Shandong University, Jinan City, Shandong, China. ;
期刊:Long non-coding DANCR targets miR-185-5p to upregulate LIM and SH3 protein 1 promoting prostate cancer via the FAK/PI3K/AKT/GSK3β/snail pathway
DOI:10.1002/jgm.3344
影响因子 :3.5
引用产品: 人前列腺上皮细胞完全培养基
FAQs
Q:{{item.question}}
A:
产品资料
识别码示意图